Report overview
Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.
This report aims to provide a comprehensive presentation of the global market for Swine Reproductive and Respiratory Syndrome Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Reproductive and Respiratory Syndrome Vaccine. This report contains market size and forecasts of Swine Reproductive and Respiratory Syndrome Vaccine in global, including the following market information:
Global Swine Reproductive and Respiratory Syndrome Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Swine Reproductive and Respiratory Syndrome Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Swine Reproductive and Respiratory Syndrome Vaccine companies in 2022 (%)
The global Swine Reproductive and Respiratory Syndrome Vaccine market was valued at US$ 436.7 million in 2022 and is projected to reach US$ 838.1 million by 2029, at a CAGR of 9.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Boehringer ingelheim is the company with the largest market share, about 25 percent.
We surveyed the Swine Reproductive and Respiratory Syndrome Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Swine Reproductive and Respiratory Syndrome Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Swine Reproductive and Respiratory Syndrome Vaccine Market Segment Percentages, by Type, 2022 (%)
Active Vaccine
Inactivated Vaccines
Global Swine Reproductive and Respiratory Syndrome Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Swine Reproductive and Respiratory Syndrome Vaccine Market Segment Percentages, by Application, 2022 (%)
Government Tender
Market Sales
Global Swine Reproductive and Respiratory Syndrome Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Swine Reproductive and Respiratory Syndrome Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Swine Reproductive and Respiratory Syndrome Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Swine Reproductive and Respiratory Syndrome Vaccine revenues share in global market, 2022 (%)
Key companies Swine Reproductive and Respiratory Syndrome Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Swine Reproductive and Respiratory Syndrome Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ASCENT CORPORATION
Boehringer-Ingelheim
MSD Animal Health
SPAH
Ceva
Chengdu TECH-BANK Biological Products Co,.Ltd
ringpu
QILU ANIMAL HEALTH PRODUCTS CO.,LTD
DAHUANONG
CAVAC
Komipharm
Agrovet
Bioveta
JINYU BIO-TECNOLOGY CO.,LTD
Phibro Animal Health
ANHUI TIANKANG(GROUP)SHRES O., LTD
Zoetis
WINSUN BIO
PULIKE BIOLOGICAL ENGINERING,INC.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Swine Reproductive and Respiratory Syndrome Vaccine, market overview.
Chapter 2: Global Swine Reproductive and Respiratory Syndrome Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Swine Reproductive and Respiratory Syndrome Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Swine Reproductive and Respiratory Syndrome Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Swine Reproductive and Respiratory Syndrome Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
